TidyMass2: Advancing LC-MS Untargeted Metabolomics Through Metabolite Origin Inference and Metabolic Feature-based Functional Module Analysis DOI Creative Commons
Xiao Wang, Yijiang Liu, Chao Jiang

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2025, Volume and Issue: unknown

Published: May 14, 2025

Abstract Untargeted metabolomics provides a direct window into biochemical activities but faces critical challenges in determining metabolite origins and interpreting unannotated metabolic features. Here, we present TidyMass2, an enhanced computational framework for Liquid Chromatography-Mass Spectrometry (LC-MS) untargeted that addresses these limitations. TidyMass2 introduces three major innovations compared its predecessor, TidyMass: (1) comprehensive origin inference capability traces metabolites to human, microbial, dietary, pharmaceutical, environmental sources through integration of 11 databases containing 532,488 with source information; (2) feature-based functional module analysis approach bypasses the annotation bottleneck by leveraging network topology extract biological insights from features; (3) intuitive graphical interface makes advanced analyses accessible researchers without programming expertise. Applied longitudinal urine data human pregnancy, identified diverse originating microbiome, environment, uncovered 27 dysregulated modules. It increased proportion biologically interpretable features 5.8% 58.8%, revealing coordinated changes steroid hormone biosynthesis, carbohydrate metabolism, amino acid processing. By expanding interpretation beyond conventionally MS 2 spectra-based annotated metabolites, enables more phenotyping while upholding strict open-source principles reproducibility, traceability, transparency.

Language: Английский

Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment DOI Creative Commons
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2024, Volume and Issue: unknown

Published: Dec. 1, 2024

Language: Английский

Citations

25

Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System DOI
Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis

et al.

Trends in Cardiovascular Medicine, Journal Year: 2025, Volume and Issue: 35(4), P. 258 - 265

Published: Jan. 21, 2025

Language: Английский

Citations

5

Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges DOI Creative Commons
Francisco Westermeier, Enrique Z. Fisman

Cardiovascular Diabetology, Journal Year: 2025, Volume and Issue: 24(1)

Published: Jan. 29, 2025

Language: Английский

Citations

3

MASLD as a non-communicable disease DOI
Silvia Sookoian, Carlos J. Pirola, Arun J. Sanyal

et al.

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 4, 2025

Language: Английский

Citations

3

Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine DOI
Norbert Stefan, Giovanni Targher

Nature Reviews Gastroenterology & Hepatology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 26, 2025

Language: Английский

Citations

2

Fatty Liver Index vs. Biochemical–Anthropometric Indices: Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease with Non-Invasive Tools DOI Creative Commons
Selim Demirci, Semih Sezer

Diagnostics, Journal Year: 2025, Volume and Issue: 15(5), P. 565 - 565

Published: Feb. 26, 2025

Background/Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a significant global burden, attributed to its increasing prevalence and strong correlation with metabolic syndrome related conditions. Timely diagnosis intervention are essential for minimizing the impact of MASLD. This study sought analyze efficacy advanced anthropometric indices non-invasive steatosis markers in diagnosing Methods: cross-sectional retrospective evaluated data from 578 Turkish patients admitted our gastroenterology clinic. MASLD was diagnosed based on internationally recognized criteria. The parameters included body mass index (BMI); waist-hip ratio (WHR); waist-height (WHtR); roundness (BRI); conicity (CI); shape (ABSI); visceral adiposity (VAI); abdominal volume (AVI); lipid accumulation product (LAP); fatty (FLI); hepatic (HSI); triglyceride-glucose (TyG) variants TyG-waist circumference(WC) TyG-BMI. Results: Among 215 men, 103 (56.9%) met criteria MASLD, while 260 out 363 women (65.5%) fulfilled In receiver operating characteristic (ROC) analysis identifying TyG-WC (0.826), TyG-BMI (0.820), FLI (0.830) achieved highest area under curve (AUC) values, statistically differences observed their pairwise comparisons against other parameters. Conclusions: comparable terms simplicity calculation superior diagnostic accuracy, making them valuable alternatives screening diagnosis.

Language: Английский

Citations

0

Subtypes of MASLD confer distinct clinical trajectories DOI
Panu K. Luukkonen

Journal of Hepatology, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis DOI
Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii

et al.

Journal of Gastroenterology, Journal Year: 2025, Volume and Issue: unknown

Published: March 18, 2025

Language: Английский

Citations

0

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies DOI
Parag Jain,

Akanksha Jain,

Rohitas Deshmukh

et al.

Clinics and Research in Hepatology and Gastroenterology, Journal Year: 2025, Volume and Issue: unknown, P. 102584 - 102584

Published: March 1, 2025

Language: Английский

Citations

0

Fat, fibrosis, and the future: navigating the maze of MASLD/MASH DOI Creative Commons
Scott L. Friedman

Journal of Clinical Investigation, Journal Year: 2025, Volume and Issue: 135(7)

Published: March 31, 2025

Language: Английский

Citations

0